Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin A Harvey

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Nutritional Biochemistry|October 2, 2007
Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular healthRafat A Siddiqui, Kevin A Harvey, Gary P Zaloga
Molecular and Cellular Biochemistry|April 20, 2010
Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiationKevin A Harvey, Zachary Welch, Daniel Sliva, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|September 26, 2006
Trans fatty acids and coronary heart diseaseGary P Zaloga, Kevin A Harvey, William Stillwell, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 24, 2007
Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition supportRafat A Siddiqui, Kevin A Harvey, Gary P Zaloga, et al.
The Journal of Biological Chemistry|November 20, 2003
SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitroGeorge Boguslawski, Patrick W McGlynn, Kevin A Harvey, et al.
Journal of Cellular Physiology|December 15, 2006
Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activationKevin A Harvey, Corine Nivanka Paranavitana, Gary P Zaloga, et al.
Bioorganic & Medicinal Chemistry|February 16, 2010
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cellsKevin A Harvey, Zhidong Xu, Phillip Whitley, et al.
Lipids|June 12, 2012
Trans fatty acids: induction of a pro-inflammatory phenotype in endothelial cellsKevin A Harvey, Candace L Walker, Zhidong Xu, et al.
Biochemical and Biophysical Research Communications|July 14, 2011
A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell linesJeffrey D Altenburg, Kevin A Harvey, Sharon McCray, et al.
European Journal of Lipid Science and Technology : EJLST|February 17, 2015
Tocopherol and tocotrienol homologs in parenteral lipid emulsionsZhidong Xu, Kevin A Harvey, Thomas M Pavlina, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Nutritional Biochemistry|October 2, 2007
Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular healthRafat A Siddiqui, Kevin A Harvey, Gary P Zaloga
Molecular and Cellular Biochemistry|April 20, 2010
Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiationKevin A Harvey, Zachary Welch, Daniel Sliva, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|September 26, 2006
Trans fatty acids and coronary heart diseaseGary P Zaloga, Kevin A Harvey, William Stillwell, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 24, 2007
Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition supportRafat A Siddiqui, Kevin A Harvey, Gary P Zaloga, et al.
The Journal of Biological Chemistry|November 20, 2003
SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitroGeorge Boguslawski, Patrick W McGlynn, Kevin A Harvey, et al.
Journal of Cellular Physiology|December 15, 2006
Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activationKevin A Harvey, Corine Nivanka Paranavitana, Gary P Zaloga, et al.
Bioorganic & Medicinal Chemistry|February 16, 2010
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cellsKevin A Harvey, Zhidong Xu, Phillip Whitley, et al.
Lipids|June 12, 2012
Trans fatty acids: induction of a pro-inflammatory phenotype in endothelial cellsKevin A Harvey, Candace L Walker, Zhidong Xu, et al.
Biochemical and Biophysical Research Communications|July 14, 2011
A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell linesJeffrey D Altenburg, Kevin A Harvey, Sharon McCray, et al.
European Journal of Lipid Science and Technology : EJLST|February 17, 2015
Tocopherol and tocotrienol homologs in parenteral lipid emulsionsZhidong Xu, Kevin A Harvey, Thomas M Pavlina, et al.
Pageof 3